Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ALVOW
#6758
Alvotech - Warrant
0.490
0
USD
+0.09%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+9.07%
Monthly Change
+157.76%
6 month change
+40.00%
Year Change
-60.48%
Previous Close
0.490
0
Open
0.490
0
Low
0.490
0
High
0.490
0
Volume
1
Markets
US Stock Market
Healthcare
Drug Manufacturers—Specialty & Generic
ALVOW
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q4, 25
Current
Key stats
Total common shares outstanding
312.02 M
312.02 M
Valuation ratios
Enterprise value
—
—
Price to earnings ratio
—
—
Price to sales ratio
—
—
Price to cash flow ratio
—
—
Price to book ratio
—
—
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
—
—
Return on equity %
—
—
Return on invested capital %
—
—
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
—
—
Current ratio
—
—
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
—
—
Long term debt to total equity ratio
—
—
Per share metrics
Operating cash flow per share
—
—
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
—
—
Cash per share
—
—
Net current asset value per share
—
—
Tangible book value per share
—
—
Working capital per share
—
—
Book value per share
—
—
News
AbbVie: Strong Q2 And New Catalysts Keep Me Bullish (NYSE:ABBV)
I Was Wrong About Johnson & Johnson: Upgrading To Hold (Rating Upgrade) (NYSE:JNJ)
Johnson & Johnson: Why I See Downside Ahead (NYSE:JNJ)
Royce Smaller-Companies Growth Fund FY 2025: What Worked… And What Didn’t
Alvotech: Why FDA Delays Don't Break The Bull Case (NASDAQ:ALVO)
Teva Pharmaceuticals: Why It’s Time To Cash Out (Downgrade) (NYSE:TEVA)
Alvotech: Initiating With Hold Rating On FDA CRL AVT05 And Reduced EBITDA Guidance (ALVO)
Johnson & Johnson Q3 Earnings Surprise, Icotrokinra Shines Again (NYSE:JNJ)
My Top 5 Biotech Stocks Big Pharma Could Buy Next
Alvotech (ALVO) Presents at Morgan Stanley 23rd Annual Global
Alvotech 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:ALVO)
Alvotech (ALVO) Q2 2025 Earnings Call Transcript